Literature DB >> 9327301

Comparison of specific and nonspecific factors in a group cognitive therapy for depression.

T P Oei1, G J Shuttlewood.   

Abstract

Research into the efficacy of psychotherapy has often reported equivalence in treatment outcome when comparing different therapies. These findings have been interpreted as evidence for what are variously termed placebo, common or nonspecific processes. We suggested that this issue is best examined in comparison of specific and nonspecific processes in the action of a specified therapy and disorder. No comparisons of this nature have yet been reported in relation to cognitive therapy for depression. This study compared specific processes (automatic thoughts and dysfunctional attitudes) and major common processes (satisfaction with therapy and client evaluation of therapist) in the action of a group cognitive therapy for depression. Sixty patients suffering from major depression received a 12 week course of group cognitive therapy. Results from hierarchical regression suggested that the specific processes of cognitive therapy were more associated with reduction in depression than common processes which contributed to the prediction of reduction in depression via specific processes.

Entities:  

Mesh:

Year:  1997        PMID: 9327301     DOI: 10.1016/s0005-7916(97)00019-0

Source DB:  PubMed          Journal:  J Behav Ther Exp Psychiatry        ISSN: 0005-7916


  3 in total

1.  Participants' perspectives on cognitive-behavioral therapy for adherence and depression in HIV.

Authors:  Carla Berg; Sudha Raminani; Joseph Greer; Meaghan Harwood; Steven Safren
Journal:  Psychother Res       Date:  2008-05

2.  The effectiveness of problem solving therapy in deprived South African communities: results from a pilot study.

Authors:  Edith van't Hof; Dan J Stein; Isaac Marks; Mark Tomlinson; Pim Cuijpers
Journal:  BMC Psychiatry       Date:  2011-09-30       Impact factor: 3.630

3.  Dejian mind-body intervention on depressive mood of community-dwelling adults: a randomized controlled trial.

Authors:  Agnes S Chan; Mei-Chun Cheung; Wilson J Tsui; Sophia L Sze; Dejian Shi
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-23       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.